梅斯医学MedSci APP
医路相伴,成就大医

前列腺癌风险评估得分(UCSF-CAPRA)

这是UCSF专家开发的风险评估系统,对前列腺癌的风险有较高的识别率
危险因素 评分
确诊时的年龄
2 诊断时PSA水平(ng/mL)
3 Gleason 分级(primary/secondary)
4 临床分期
5.组织切片中阳性切片比例
评分
参考文献:
Zelic R, Garmo H, Zugna D, Stattin P, Richiardi L, Akre O, Pettersson A. Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study.Eur Urol 2019 Oct 9. pii: S0302-2838(19)30755-9.
Spratt DE, Schaeffer EM. Transcriptomic Heterogeneity of Favorable-risk Prostate Cancer: Time To Move Past Cancer of the Prostate Risk Assessment (CAPRA) to Clinical-genomic Risk.Eur Urol. 2018 Oct;74(4):453-454

* 评分系统由梅斯医学-->医学量表、计算器提供支持



移动应用
medsci.cn © 2019